Concepedia

Author

Sameer Parekh

Serum Institute of India (India)ORCID

Also Known As

Parekh, Sameer, Sameer Parekh, Sameer S Parekh, Sameer S. Parekh, Shweta Parekh, Shweta Virendra Parekh

46

Publications

585

Citations

12

H-Index

42

Concepts

All Affiliations

Serum Institute of India (India)Veterinary Biological and Research InstituteBharati Vidyapeeth Deemed UniversityMaulana Azad Medical CollegeAtal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital
SP

About

Sameer Parekh is an author at Serum Institute of India (India) specializing in medicine, vaccination, and vaccine development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

127

2

Arts

1

1

31

3

Business

1

1

31

4

Engineering

1

1

31

5

Public Health

1

1

35

Sameer Parekh

×

12

Publications

505

Citations

11

H-Index

YearCitations

Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants

Sameer Parekh, Fabien Zoulim, Sang Hoon Ahn,

Journal of Virology

2003

257

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Hitt Sharma, Sameer Parekh, Pramod Pujari,

The Lancet Oncology

2023

35

Prospects for remailers

Sameer Parekh

First Monday

1996

31

Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India

Hitt Sharma, V S Padbidri, Subhash V. Kapre,

The Journal of Infection in Developing Countries

2011

30

Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children

Hitt Sharma, Sangita Yadav, Sanjay Lalwani,

Human Vaccines

2011

29

A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants

Hitt Sharma, Sangita Yadav, Sanjay Lalwani,

Vaccine

2011

27

Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls

Hitt Sharma, Sunil Chowdhari, TilakRaj Raina,

Indian Journal of Community Medicine

2010

21

Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine

Hitt Sharma, Sangeeta Yadav, Sanjay Lalwani,

Vaccine

2012

19

Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process

Hitt Sharma, Vishwanath Patil, Sanjay Lalwani,

Vaccine

2011

18

A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive bladder cancer

Rajeev Sood, Hitt Sharma, Bhuvaneshwari Sharma,

Urologic Oncology Seminars and Original Investigations

2020

15

Page 1